Picture of Takeda Pharmaceutical Co logo

TAK Takeda Pharmaceutical Co News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical Company Ltd





 




RNS Number : 2620A
Societe Generale SA
10 September 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

Société Générale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Takeda Pharmaceutical CO LTD

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure

07/09/2018

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

YES: Shire PLC

 

 

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,696,412

0.34

6,280,881

0.80

(2) Cash-settled derivatives:

 

5,259,342

0.67

2,026

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

121,500

0.02

0

0.00

 

     TOTAL:

8,077,254

1.03

6,282,907

0.80

           

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

JPY

Ordinary

Purchase

5,600

4425

Ordinary

Purchase

100

4379

Ordinary

Purchase

300

4406

Ordinary

Purchase

900

4379

Ordinary

Purchase

200

4378

Ordinary

Purchase

600

4371

Ordinary

Purchase

500

4371

Ordinary

Purchase

500

4355

Ordinary

Purchase

400

4381

Ordinary

Purchase

500

4380

Ordinary

Purchase

500

4380

Ordinary

Purchase

800

4378

Ordinary

Purchase

300

4373

Ordinary

Purchase

100

4407

Ordinary

Purchase

100

4407

Ordinary

Purchase

200

4405

Ordinary

Purchase

100

4405

Ordinary

Purchase

600

4371

Ordinary

Purchase

1,200

4354

Ordinary

Purchase

800

4376

Ordinary

Purchase

2,300

4373

Ordinary

Purchase

1,300

4423

Ordinary

Purchase

300

4423

Ordinary

Purchase

3,000

4382

Ordinary

Purchase

100

4349

Ordinary

Purchase

2,300

4354

Ordinary

Purchase

100

4371

Ordinary

Purchase

500

4363

Ordinary

Purchase

1,400

4347

Ordinary

Purchase

700

4367

Ordinary

Purchase

1,100

4372

Ordinary

Purchase

2,200

4375

Ordinary

Purchase

200

4412

Ordinary

Purchase

100

4424

Ordinary

Purchase

100

4396

Ordinary

Purchase

600

4391

Ordinary

Purchase

100

4390

Ordinary

Purchase

400

4347

Ordinary

Purchase

500

4357

Ordinary

Purchase

1,100

4360

Ordinary

Purchase

1,100

4359

Ordinary

Purchase

1,000

4377

Ordinary

Purchase

1,000

4378

Ordinary

Purchase

1,000

4383

Ordinary

Purchase

700

4384

Ordinary

Purchase

1,000

4400

Ordinary

Purchase

1,000

4400

Ordinary

Purchase

700

4368

Ordinary

Purchase

600

4345

Ordinary

Purchase

1,000

4386

Ordinary

Purchase

700

4386

Ordinary

Purchase

1,000

4394

Ordinary

Purchase

300

4394

Ordinary

Purchase

300

4400

Ordinary

Purchase

700

4346

Ordinary

Purchase

100

4400

Ordinary

Purchase

1,000

4401

Ordinary

Purchase

100

4397

Ordinary

Purchase

1,300

4349

Ordinary

Purchase

500

4393

Ordinary

Purchase

1,000

4392

Ordinary

Purchase

1,100

4368

Ordinary

Purchase

1,100

4367

Ordinary

Purchase

200

4372

Ordinary

Purchase

400

4348.5

Ordinary

Purchase

500

4396.5

Ordinary

Purchase

400

4395

Ordinary

Purchase

600

4416

Ordinary

Purchase

100

4367

Ordinary

Purchase

300

4381

Ordinary

Purchase

1,200

4379.5

Ordinary

Purchase

400

4352

Ordinary

Purchase

700

4413

Ordinary

Purchase

400

4407

Ordinary

Purchase

100

4368

Ordinary

Purchase

200

4374

Ordinary

Purchase

2,300

4374

Ordinary

Purchase

14,200

4374

Ordinary

Purchase

100

4390

Ordinary

Purchase

300

4420

Ordinary

Purchase

100

4412

Ordinary

Purchase

100

4410

Ordinary

Purchase

200

4405

Ordinary

Purchase

100

4407

Ordinary

Purchase

174

4488

Ordinary

Sale

14,700

4374

Ordinary

Sale

300

4375

Ordinary

Sale

300

4410

Ordinary

Sale

200

4410

Ordinary

Sale

500

4375

Ordinary

Sale

100

4345

Ordinary

Sale

1,300

4395

Ordinary

Sale

100

4400

Ordinary

Sale

700

4398

Ordinary

Sale

200

4384

Ordinary

Sale

400

4369

Ordinary

Sale

200

4397

Ordinary

Sale

1,300

4416

Ordinary

Sale

100

4376

Ordinary

Sale

900

4363

Ordinary

Sale

700

4366

Ordinary

Sale

500

4369

Ordinary

Sale

200

4366

Ordinary

Sale

500

4369

Ordinary

Sale

800

4369

Ordinary

Sale

100

4366

Ordinary

Sale

1,800

4366

Ordinary

Sale

700

4361

Ordinary

Sale

1,700

4377

Ordinary

Sale

200

4410

Ordinary

Sale

100

4368

Ordinary

Sale

1,100

4388

Ordinary

Sale

100

4361

Ordinary

Sale

1,500

4380

Ordinary

Sale

200

4345

Ordinary

Sale

1,200

4354

Ordinary

Sale

1,400

4398

Ordinary

Sale

500

4368

Ordinary

Sale

600

4384

Ordinary

Sale

800

4385

Ordinary

Sale

2,300

4373

Ordinary

Sale

100

4417

Ordinary

Sale

1,000

4418

Ordinary

Sale

1,700

4384

Ordinary

Sale

2,300

4352

Ordinary

Sale

100

4386

Ordinary

Sale

1,300

4395

Ordinary

Sale

300

4384

Ordinary

Sale

300

4368

Ordinary

Sale

200

4396

Ordinary

Sale

800

4411

Ordinary

Sale

200

4344

Ordinary

Sale

100

4419

Ordinary

Sale

1,100

4419

Ordinary

Sale

400

4420

Ordinary

Sale

1,000

4398

Ordinary

Sale

100

4398

Ordinary

Sale

1,300

4395

Ordinary

Sale

700

4405

Ordinary

Sale

1,300

4378

Ordinary

Sale

100

4417

Ordinary

Sale

600

4409

Ordinary

Sale

1,700

4380

Ordinary

Sale

800

4415

Ordinary

Sale

200

4403

Ordinary

Sale

200

4408

Ordinary

Sale

100

4399

Ordinary

Sale

200

4399

Ordinary

Sale

200

4403

Ordinary

Sale

300

4397

Ordinary

Sale

100

4383

Ordinary

Sale

300

4384

Ordinary

Sale

800

4384

Ordinary

Sale

100

4384

Ordinary

Sale

1,000

4384

Ordinary

Sale

200

4403

Ordinary

Sale

100

4398

Ordinary

Sale

200

4410

Ordinary

Sale

200

4408

Ordinary

Sale

100

4408

Ordinary

Sale

1,300

4383

Ordinary

Sale

400

4405

Ordinary

Sale

1,000

4372

Ordinary

Sale

1,000

4426

Ordinary

Sale

1,100

4350

Ordinary

Sale

900

4378

Ordinary

Sale

1,000

4374

Ordinary

Sale

1,100

4354

Ordinary

Sale

900

4374

Ordinary

Sale

1,100

4351

Ordinary

Sale

1,100

4361

Ordinary

Sale

400

4348

Ordinary

Sale

1,000

4382

Ordinary

Sale

900

4375

Ordinary

Sale

400

4355

Ordinary

Sale

1,000

4383

Ordinary

Sale

500

4414

Ordinary

Sale

300

4385

Ordinary

Sale

200

4380.5

Ordinary

Sale

200

4364.5

Ordinary

Sale

200

4368.5

Ordinary

Sale

100

4380

Ordinary

Sale

1,900

4374

Ordinary

Sale

800

4374

Ordinary

Sale

100

4379

Ordinary

Sale

8,000

4374

Ordinary

Sale

100

4354

Ordinary

Sale

11,000

4374

Ordinary

Sale

189

4558

 

Total Purchases

74,074

 

 

Total Sales

98,289

 

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit JPY

 

 

 

 

 

 

 (c)       Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit JPY

 

 

 

 

 

 

 

 

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit JPY

 

 

 

 

 

 

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) JPY

 

 

 

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c)        Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES

 

 

Date of disclosure:

10/09/2018

Contact name:

Olivier Vero

Telephone number:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

 

 

 

                                                                 

 

 

 

 

 

                                                                SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1.         KEY INFORMATION

 

Full name of person making disclosure:

SOCIETE GENERALE SA

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Takeda Pharmaceutical CO LTD

 

2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

Expiry date

JPY

e.g. American, European etc.

Ordinary

OTC put-option

Sale

15,700

4707

European options

14/12/2018

Ordinary

OTC put-option

Sale

30,000

5075.10

European options

14/12/2018

Ordinary

OTC put-option

Sale

29,600

5073.65

European options

14/12/2018

Ordinary

OTC put-option

Sale

15,500

4491.40

European options

14/12/2018

Ordinary

OTC put-option

Sale

30,700

4533.90

European options

14/12/2018

 

 

 

3.         AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETSFWSASFASELU

Recent news on Takeda Pharmaceutical Co

See all news